BioWorld

March 22, 2000

View Archived Issues

Live Weakened Rabies Virus Signs On As Vector In Protective, Two-Armed Anti-HIV-1 Vaccine

Read More

Aclara's Stock Skyrockets As Its IPO Raises $189 Million

Read More

Triangle Spins Out New Firm Focused On Health Information

Read More

HGS Receives Phage Display Through $16M Pact With Dyax

Read More

Enzon Raises $83M To Develop PEG and SCA Compounds

Read More

Other News To Note

Read More

Abgenix, Corixa To Battle For Antibody Rights In Auction

Read More

Celera Buys Paracel In Stock Swap To Boost Bioinformatics

Read More